# PGLYRP1

## Overview
PGLYRP1, or peptidoglycan recognition protein 1, is a gene that encodes a secretory protein involved in the innate immune response. The protein, also known as Tag7, is part of a novel class of bactericidal proteins that recognize bacterial peptidoglycan, a key component of bacterial cell walls. Unlike traditional antimicrobial peptides, PGLYRP1 is a larger, disulfide-linked glycosylated dimer that requires divalent cations and N-glycosylation for its bactericidal activity (Dziarski2006Thepeptidoglycanrecognitionproteins(PGRPs) page 3 of 4; Osanai2011Mouse page 0 of 6). It plays a crucial role in the immune system by acting as an opsonin and enhancing cytokine secretion, thereby modulating the immune response to bacterial infections (Slonova2020Human; Yang2019Human). PGLYRP1 is also involved in interactions with other proteins, such as those in the NOD2 pathway, which are essential for intracellular peptidoglycan detection and mucosal protection (Reinecker2024PGLYRP1). Its clinical significance is underscored by its role in diseases like pancreatic ductal adenocarcinoma and Lyme borreliosis, where it influences immune responses and disease progression (López-Gil2024The; Gupta2020A).

## Structure
PGLYRP1, also known as Tag7, is a protein involved in the immune response, characterized by its ability to recognize bacterial peptidoglycan. The protein is a disulfide-linked glycosylated dimer, which is larger than typical antimicrobial peptides and requires divalent cations and N-glycosylation for its bactericidal activity (Dziarski2006Thepeptidoglycanrecognitionproteins(PGRPs) page 3 of 4). The molecular structure of PGLYRP1 includes a ligand-binding groove that specifically targets MurNAc bound to three peptide-bonded amino acids, burying both the peptide and MurNAc portions in a deep cleft to exclude solvent (Dziarski2006Thepeptidoglycanrecognitionproteins(PGRPs) page 3 of 4).

PGLYRP1 is part of a new class of bactericidal proteins that differ from traditional antimicrobial peptides in size, structure, and mechanism of action. It is a secretory protein that forms dimers, and its antimicrobial activities are enhanced by metal ions such as calcium and zinc (Osanai2011Mouse). The protein's structure includes conserved cysteines that form disulfide bonds necessary for its activity, and it features a carboxy-terminal type 2 amidase domain, approximately 165 amino acids long, homologous to bacteriophage and bacterial type 2 amidases (Dziarski2006Thepeptidoglycanrecognitionproteins(PGRPs) page 0 of 4).

## Function
PGLYRP1, or peptidoglycan recognition protein 1, is a crucial component of the innate immune system, primarily involved in recognizing bacterial peptidoglycan. It is expressed in the granules of polymorphonuclear leukocytes (PMNs) and plays a significant role in the immune response by aiding in the killing of both intracellular and extracellular bacteria (Yang2019Human). PGLYRP1 functions as an opsonin, enhancing the immune system's ability to recognize and phagocytize bacteria, although it does not exhibit direct bactericidal effects (Slonova2020Human). 

In macrophages, PGLYRP1 enhances cytokine secretion, such as IL-6, following bacterial infection, thereby modulating the immune response (Slonova2020Human). It also acts as a ligand for the TREM-1 receptor on myeloid cells, which is important for amplifying inflammation during bacterial infections (Read2015Cutting). PGLYRP1 does not directly stimulate reactive oxygen species production but can potentiate the response when combined with stimuli like PMA, indicating its role in enhancing certain immune responses (Slonova2020Human). Overall, PGLYRP1 is integral to the immune response, facilitating bacterial recognition and modulating inflammation.

## Clinical Significance
PGLYRP1 (peptidoglycan recognition protein 1) plays a significant role in various diseases due to its involvement in immune responses. In pancreatic ductal adenocarcinoma (PDAC), PGLYRP1 is overexpressed in cancer stem cells, contributing to immune evasion and tumor progression. Its expression is linked to reduced immune cell infiltration and increased tumor aggressiveness, making it a potential biomarker for PDAC and a target for therapeutic intervention (López-Gil2024The).

In the context of Lyme borreliosis, PGLYRP1 is crucial for controlling the infection caused by Borrelia burgdorferi. Deficiency in PGLYRP1 leads to higher bacterial loads in tissues, indicating its role in limiting bacterial dissemination. Despite this, PGLYRP1 deficiency does not correlate with increased disease severity, suggesting a complex relationship between pathogen load and disease outcomes (Gupta2020A).

Alterations in PGLYRP1 expression or function can impact immune responses, potentially influencing the severity and progression of diseases. Its role in immune modulation highlights its clinical significance in both cancer and infectious diseases, making it a promising target for future research and therapeutic strategies (López-Gil2024The).

## Interactions
Peptidoglycan recognition protein 1 (PGLYRP1) is involved in several interactions with other proteins, playing a significant role in the immune response. PGLYRP1 interacts with the NOD2 pathway, forming complexes with NOD2 and GEF-H1, which are crucial for signaling in response to peptidoglycan fragments like GMTriP-K. These interactions occur in the endoplasmic reticulum (ER) and Golgi apparatus, suggesting a mechanism where PGLYRP1, through its association with NOD2 and GEF-H1, plays a role in intracellular peptidoglycan detection and mucosal protection (Reinecker2024PGLYRP1).

PGLYRP1 also forms complexes with Sec61β, a component of the Sec61 protein translocon complex, and GM130, a cis-Golgi matrix protein, indicating its involvement in the transition from ER to Golgi-associated membrane complexes. This interaction is enhanced upon stimulation with GMTriP-K, highlighting the role of GEF-H1 as a signaling hub that facilitates PGLYRP1 signaling (Reinecker2024PGLYRP1).

In the context of Lyme borreliosis, PGLYRP1 binds to the peptidoglycan of Borrelia burgdorferi, the bacterium responsible for the disease, and enhances the host's immune response against the pathogen. This interaction is crucial for controlling the infection and modulating immune responses (Gupta2020A).


## References


[1. (López-Gil2024The) Juan Carlos López-Gil, Susana García-Silva, Laura Ruiz-Cañas, Diego Navarro, Adrián Palencia-Campos, Antonio Giráldez-Trujillo, Julie Earl, Jorge Dorado, Gonzalo Gómez-López, Ana Monfort-Vengut, Sonia Alcalá, Matthias M Gaida, Sandra García-Mulero, Pablo Cabezas-Sáinz, Sandra Batres-Ramos, Emma Barreto, Patricia Sánchez-Tomero, Mireia Vallespinós, Leah Ambler, Meng-Lay Lin, Alexandra Aicher, Ana García García de Paredes, Carolina de la Pinta, Alfonso Sanjuanbenito, Ignacio Ruz-Caracuel, Mercedes Rodríguez-Garrote, Carmen Guerra, Alfredo Carrato, Guillermo de Cárcer, Laura Sánchez, César Nombela-Arrieta, Elisa Espinet, Víctor Javier Sanchez-Arevalo Lobo, Christopher Heeschen, and Bruno Sainz. The peptidoglycan recognition protein 1 confers immune evasive properties on pancreatic cancer stem cells. Gut, pages gutjnl-2023-330995, May 2024. URL: http://dx.doi.org/10.1136/gutjnl-2023-330995, doi:10.1136/gutjnl-2023-330995. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1136/gutjnl-2023-330995)

[2. (Read2015Cutting) Christine B. Read, Joseph L. Kuijper, Siv A. Hjorth, Mark D. Heipel, Xiaoting Tang, Andrew J. Fleetwood, Jeffrey L. Dantzler, Susanne N. Grell, Jesper Kastrup, Camilla Wang, Cameron S. Brandt, Anker J. Hansen, Nicolai R. Wagtmann, Wenfeng Xu, and Vibeke W. Stennicke. Cutting edge: identification of neutrophil pglyrp1 as a ligand for trem-1. The Journal of Immunology, 194(4):1417–1421, February 2015. URL: http://dx.doi.org/10.4049/jimmunol.1402303, doi:10.4049/jimmunol.1402303. This article has 121 citations.](https://doi.org/10.4049/jimmunol.1402303)

[3. (Yang2019Human) Jie Yang. Human peptidoglycan recognition protein 1 in innate immunity – a review. Pakistan Journal of Zoology, 2019. URL: http://dx.doi.org/10.17582/journal.pjz/2019.51.3.rev1, doi:10.17582/journal.pjz/2019.51.3.rev1. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.17582/journal.pjz/2019.51.3.rev1)

4. (Reinecker2024PGLYRP1) PGLYRP-1 mediated intracellular peptidoglycan detection promotes mucosal protection. This article has 0 citations.

[5. (Osanai2011Mouse) Arihiro Osanai, Hiroshi Sashinami, Krisana Asano, Sheng-Jun Li, Dong-Liang Hu, and Akio Nakane. Mouse peptidoglycan recognition protein pglyrp-1 plays a role in the host innate immune response againstlisteria monocytogenesinfection. Infection and Immunity, 79(2):858–866, February 2011. URL: http://dx.doi.org/10.1128/iai.00466-10, doi:10.1128/iai.00466-10. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1128/iai.00466-10)

[6. (Gupta2020A) Akash Gupta, Gunjan Arora, Connor E. Rosen, Zachary Kloos, Yongguo Cao, Jiri Cerny, Andaleeb Sajid, Dieuwertje Hoornstra, Maryna Golovchenko, Natalie Rudenko, Ulrike Munderloh, Joppe W. Hovius, Carmen J. Booth, Christine Jacobs-Wagner, Noah W. Palm, Aaron M. Ring, and Erol Fikrig. A human secretome library screen reveals a role for peptidoglycan recognition protein 1 in lyme borreliosis. PLOS Pathogens, 16(11):e1009030, November 2020. URL: http://dx.doi.org/10.1371/journal.ppat.1009030, doi:10.1371/journal.ppat.1009030. This article has 13 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.ppat.1009030)

[7. (Dziarski2006Thepeptidoglycanrecognitionproteins(PGRPs) page 2 of 4) Roman Dziarski and Dipika Gupta. The peptidoglycan recognition proteins (pgrps). Genome Biology, 7(8):232, 2006. URL: http://dx.doi.org/10.1186/gb-2006-7-8-232, doi:10.1186/gb-2006-7-8-232. This article has 442 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/gb-2006-7-8-232)

[8. (Slonova2020Human) Darya Slonova, Alexandra Posvyatenko, Alexey Kibardin, Elena Sysolyatina, Elena Lyssuk, Svetlana Ermolaeva, Sergei Obydennyi, Nikolay Gnuchev, Georgii Georgiev, Konstantin Severinov, and Sergey Larin. Human short peptidoglycan recognition protein pglyrp1/tag-7/pgrp-s inhibits listeria monocytogenes intracellular survival in macrophages. Frontiers in Cellular and Infection Microbiology, December 2020. URL: http://dx.doi.org/10.3389/fcimb.2020.582803, doi:10.3389/fcimb.2020.582803. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcimb.2020.582803)